Replimune Group, Inc. - Common Stock (NQ:REPL)
All News about Replimune Group, Inc. - Common Stock
Via NewMediaWire
    
   
    Replimune Announces Type A Meeting Scheduled with FDA
    
   September 02, 2025
   From Replimune, Inc.
   Via GlobeNewswire
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
